Library

X
feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • 2000-2004  (2)
  • 1
    Electronic Resource
    Electronic Resource
    Post-menopausal frontal fibrosing alopecia (2003)
    Oxford, UK : Blackwell Science Ltd
    Clinical and experimental dermatology 28 (2003), S. 0 
    Details
    ISSN: 1365-2230
    Source: Blackwell Publishing Journal Backfiles 1879-2005
    Topics: Medicine
    Notes: Post-menopausal frontal fibrosing alopecia (PFFA) has become an increasingly recognized distinct clinical entity in recent years. Most cases have been reported from Australia; however, it seems likely that the condition is under-recognized. PFFA has similarities to lichen planopilaris but is differentiated by a distinctive symmetrical fronto-temporal distribution and progressive course. We report two cases from the UK and review the literature.
    Type of Medium: Electronic Resource
    URL: http://dx.doi.org/10.1046/j.1365-2230.2003.01140.x
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
    Paper (German National Licenses)
    Fulltext
  • 2
    Electronic Resource
    Electronic Resource
    Hepatocellular carcinoma after long-term tamoxifen therapy (2000)
    Springer
    Annals of oncology 11 (2000), S. 1195-1196 
    Details
    ISSN: 1569-8041
    Keywords: hepatocellular carcinoma ; tamoxifen
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract We describe a case of hepatocellular carcinoma (HCC) after long termtamoxifen therapy in a 71-year-old woman. The patient was prescribed tamoxifenfor 12 years following right mastectomy and axillary node clearance for breastcarcinoma in 1985. In 1997, she complained of abdominal pain and fullness. Anabdominal ultrasound scan showed lesions in the right lobe of liver which werethought to be metastases. However, a biopsy showed primary HCC. Studies inrats suggest that tamoxifen is involved in hepatic carcinogenesis but studiesin humans have failed to show any increased risk. However, these studiesfollowed up patients for less than five years. An increased risk of HCC maynot become apparent until after a decade or more of tamoxifen therapy. Inaddition, HCC in tamoxifen treated patients may be under-reported since theremay be reluctance to biopsy liver tumours which are assumed to be secondarycarcinoma of the breast.
    Type of Medium: Electronic Resource
    URL: http://dx.doi.org/10.1023/A:1008354429921
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
    Paper (German National Licenses)
    Fulltext
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...